Esken Limited
ESKNF · OTC
8/31/2023 | 2/28/2023 | 8/31/2022 | 2/28/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -92.6% | 6.4% | 11.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | -51% | -13% | -11.7% | 26.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | -$0 | -$0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -150.4% | -10.3% | -10.8% | -7.7% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$0 |
| Tax Expense | -$0 | $0 | -$0 | -$0 |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,318.2% | -26.9% | -14.8% | -23.6% |
| EPS | -0.03 | -0.016 | -0.009 | -0.015 |
| % Growth | -82.2% | -91.8% | 43% | – |
| EPS Diluted | -0.03 | -0.016 | -0.008 | -0.015 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -50.1% | 9.3% | 7.6% | 5.8% |